![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yuyu Lv, Ru Ren, Chengxiang Tang, Kuimeng Song, Shunping Li & Haipeng Wang. (2022) Preferences for Patients with Type 2 Diabetes Mellitus for Medications in Shandong Province, China: A Discrete Choice Experiment. Patient Preference and Adherence 16, pages 2335-2344.
Read now
Read now
Vivian T Thieu, Susan Robinson, Tessa Kennedy-Martin, Kristina S Boye & Luis-Emilio Garcia-Perez. (2019) Patient preferences for glucagon-like peptide 1 receptor–agonist treatment attributes. Patient Preference and Adherence 13, pages 561-576.
Read now
Read now
Katie D Stewart, Joseph A Johnston, Louis S Matza, Sarah E Curtis, Henry A Havel, Stephanie A Sweetana & Heather L Gelhorn. (2016) Preference for pharmaceutical formulation and treatment process attributes. Patient Preference and Adherence 10, pages 1385-1399.
Read now
Read now
Heather L Gelhorn, Jiat-Ling Poon, Evan W Davies, Rosirene Paczkowski, Sarah E Curtis & Kristina S Boye. (2015) Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK. Patient Preference and Adherence 9, pages 1611-1622.
Read now
Read now
Carlos Morillas, Rosa Feliciano, Pablo Fernández Catalina, Carla Ponte, Marta Botella, João Rodrigues, Enric Esmatjes, Javier Lafita, Luis Lizán, Ignacio Llorente, Cristóbal Morales, Jorge Navarro-Pérez, Domingo Orozco-Beltran, Silvia Paz, Antonio Ramirez de Arellano, Cristina Cardoso & Maribel Tribaldos Causadias. (2015) Patients’ and physicians’ preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment. Patient Preference and Adherence 9, pages 1443-1458.
Read now
Read now
A Brett Hauber, Steven Han, Jui-Chen Yang, Ira Gantz, Kaan Tunceli, Juan Marcos Gonzalez, Kimberly Brodovicz, Charles M Alexander, Michael Davies, Kristy Iglay, Qiaoyi Zhang & Larry Radican. (2013) Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Preference and Adherence 7, pages 937-949.
Read now
Read now
Articles from other publishers (12)
Yuankai Huang, Qixiang Huang, Ailin Xu, Mengqing Lu & Xiaoyu Xi. (2022) Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment. Frontiers in Public Health 9.
Crossref
Crossref
Louis S. Matza, Katelyn N. Cutts, Katie D. Stewart, Kirsi Norrbacka, Luis-Emilio García-Pérez & Kristina S. Boye. (2021) Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes. Quality of Life Research 30:7, pages 2033-2043.
Crossref
Crossref
Ahuja Nirmal, Kristin Sznajder, Rajendra Patil & Bushra Shaikh. (2021) Preference of inhalants over pills/injections among pulmonary tuberculosis patients in Western India: A cross-sectional study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 23, pages 100234.
Crossref
Crossref
Dhiren Patel. (2020) Glycaemic and non‐glycaemic efficacy of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes. Journal of Clinical Pharmacy and Therapeutics 45:S1, pages 28-42.
Crossref
Crossref
Jens Juul Holst. (2020) Incretin therapy for diabetes mellitus type 2. Current Opinion in Endocrinology, Diabetes & Obesity 27:1, pages 2-10.
Crossref
Crossref
Simon Fifer, John Rose, Kim K. Hamrosi & Dan Swain. (2018) Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment. BMC Health Services Research 18:1.
Crossref
Crossref
Vladislav A Zykov, Taisiia P Tuchina, Denis A Lebedev, Irina B Krylova, Alina Y Babenko, Elvira V Kuleshova, Elena N Grineva, Alekber A Bayramov & Michael M Galagudza. (2018) Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus. World Journal of Diabetes 9:9, pages 149-156.
Crossref
Crossref
Donna Rowen, Katherine Stevens, Alexander Labeit, Jackie Elliott, Brendan Mulhern, Jill Carlton, Hasan Basarir, Julie Ratcliffe & John Brazier. (2018) Using a Discrete-Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes. Value in Health 21:1, pages 69-77.
Crossref
Crossref
Anna Rydén, Stephanie Chen, Emuella Flood, Beverly Romero & Susan Grandy. (2017) Discrete Choice Experiment Attribute Selection Using a Multinational Interview Study: Treatment Features Important to Patients with Type 2 Diabetes Mellitus. The Patient - Patient-Centered Outcomes Research 10:4, pages 475-487.
Crossref
Crossref
Lill-Brith von Arx, F. Reed Johnson, Morten Raun Mørkbak & Trine Kjær. (2017) Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients’ Benefit-Risk Tradeoff Preferences. Value in Health 20:4, pages 670-678.
Crossref
Crossref
A. Higgins, J. Barnett, C. Meads, J. Singh & L. Longworth. (2014) Does Convenience Matter in Health Care Delivery? A Systematic Review of Convenience-Based Aspects of Process Utility. Value in Health 17:8, pages 877-887.
Crossref
Crossref
Tanjala S. Purnell, Susan Joy, Emily Little, John F.P. Bridges & Nisa Maruthur. (2014) Patient Preferences for Noninsulin Diabetes Medications: A Systematic Review. Diabetes Care 37:7, pages 2055-2062.
Crossref
Crossref